0000904314-17-000001.txt : 20171114 0000904314-17-000001.hdr.sgml : 20171114 20171114133512 ACCESSION NUMBER: 0000904314-17-000001 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20171109 FILED AS OF DATE: 20171114 DATE AS OF CHANGE: 20171114 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: WEIL JOHN D CENTRAL INDEX KEY: 0000904314 STATE OF INCORPORATION: MO FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19266 FILM NUMBER: 171200225 MAIL ADDRESS: STREET 1: 200 N BROADWAY SUITE 825 CITY: ST LOUIS STATE: MO ZIP: 63102 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALLIED HEALTHCARE PRODUCTS INC CENTRAL INDEX KEY: 0000874710 STANDARD INDUSTRIAL CLASSIFICATION: ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES [3842] IRS NUMBER: 231370721 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 BUSINESS ADDRESS: STREET 1: 1720 SUBLETTE AVE CITY: ST LOUIS STATE: MO ZIP: 63110 BUSINESS PHONE: 3147712400 MAIL ADDRESS: STREET 1: 1720 SUBLETTE AVENUE CITY: ST LOUIS STATE: MO ZIP: 63110 4 1 primary_doc.xml PRIMARY DOCUMENT X0306 4 2017-11-09 0 0000874710 ALLIED HEALTHCARE PRODUCTS INC AHPH 0000904314 WEIL JOHN D 200 N BROADWAY SUITE 825 ST LOUIS MO 63102 1 0 1 0 Common Stock 53577 D Common Stock 2500 I IRA Common Stock 94427 I Spouse Common Stock 59101 I Trust Common Stock 7927 I Corporation Common Stock 119792 I Trust Common Stock 495039 I Limited Partnership Option (right to buy) 4.05 2009-11-13 2018-11-13 Common Stock 1500 1500 D Option (right to buy) 5.04 2010-11-13 2019-11-13 Common Stock 1500 1500 D Option (right to buy) 4.34 2011-11-11 2020-11-11 Common Stock 1500 1500 D Option (right to buy) 3.555 2012-11-10 2021-11-10 Common Stock 1500 1500 D Option (right to buy) 2.59 2013-11-08 2022-11-08 Common Stock 1500 1500 D Option (right to buy) 2.31 2014-11-14 2023-11-14 Common Stock 1500 1500 D Option (right to buy) 1.58 2015-11-13 2024-11-13 Common Stock 1500 1500 D Option (right to buy) 1.17 2016-11-12 2025-11-12 Common Stock 1500 1500 D Option (right to buy) 1.13 2017-11-10 2026-11-10 Common Stock 1500 1500 D Option (right to buy) 2.22 2017-11-09 4 A 0 750 A 2018-11-09 2027-11-09 Common Stock 750 750 D On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 53,577 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 2,500 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 94,428 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 59,102 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 7,926 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 119,795 fewer shares. On December 7, 2016, the issuer effected a 1-for-2 reverse stock split resulting in the reporting person's ownership of 495,040 fewer shares. The reporting person disclaims any economic benefit in such shares. Owned by a trust for the benefit of the reporting person and for which the reporting person acts as co-trustee. Owned by a family limited partnership of which the reporting person acts as one of several general partners. Number of shares reported includes all shares held by limited partnership. The reporting person disclaims beneficial ownership of shares held by the limited partnership in excess of the reporting person's proportionate interest as determined pursuant to Rule 16a-1(2)(ii)(B). Owned by a corporation controlled by the reporting person. Owned by trusts for which the reporting person acts as co-trustee and with respect to which the reporting person disclaims any economic benefit in such shares. Options may not be exercised for a period of one year from the date of the grant and thereafter are exercisable in full. John D. Weil 2017-11-14